EDGAR Filing Documents for 0001193125-15-087880

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-15-087880

Filing Date

2015-03-12

Accepted

2015-03-11 21:32:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d888098ds3.htm	S-3	364431
2	EX-1.2	d888098dex12.htm	EX-1.2	151589
3	EX-4.3	d888098dex43.htm	EX-4.3	297396
4	EX-4.4	d888098dex44.htm	EX-4.4	310535
5	EX-4.5	d888098dex45.htm	EX-4.5	34954
6	EX-4.6	d888098dex46.htm	EX-4.6	34849
7	EX-5.1	d888098dex51.htm	EX-5.1	30311
8	EX-5.2	d888098dex52.htm	EX-5.2	7789
9	EX-12	d888098dex121.htm	EX-12	7399
10	EX-23.1	d888098dex231.htm	EX-23.1	1604
11	GRAPHIC	g888098g14b53.jpg	GRAPHIC	34410
12	GRAPHIC	g888098g69k60.jpg	GRAPHIC	25805
	Complete submission text file	0001193125-15-087880.txt		1325101

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)